Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Abbvie Biotherapeutics Inc patents


Recent patent applications related to Abbvie Biotherapeutics Inc. Abbvie Biotherapeutics Inc is listed as an Agent/Assignee. Note: Abbvie Biotherapeutics Inc may have other listings under different names/spellings. We're not affiliated with Abbvie Biotherapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Abbvie Biotherapeutics Inc-related inventors


Fc variants

The present disclosure relates to polypeptide variants having modified fc domains with altered affinity to fc receptors.. . ... Abbvie Biotherapeutics Inc

Anti-cmet antibody drug conjugates and methods for their use

The present disclosure provides antibody drug conjugates that bind human cmet, their methods of making, and their uses to treat patients having cancer.. . ... Abbvie Biotherapeutics Inc

Anti-cs1 antibodies and antibody drug conjugates

The present disclosure provides antibodies and antibody drug conjugates that bind human cs1 and their uses to treat subjects diagnosed with a plasma cell neoplasm, for example, multiple myeloma.. . ... Abbvie Biotherapeutics Inc

Bispecific binding proteins

The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.. . ... Abbvie Biotherapeutics Inc

Anti-ox40 antibodies and their uses

The present disclosure provides novel anti-ox40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.. . ... Abbvie Biotherapeutics Inc

Anti-cd40 antibodies and their uses

The present disclosure provides novel anti-cd40 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.. . ... Abbvie Biotherapeutics Inc

Anti-ox40 antibodies and their uses

The present disclosure provides novel anti-ox40 antibodies, compositions including the antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.. . ... Abbvie Biotherapeutics Inc

Anti-pd-1 antibodies and their uses

The present disclosure provides novel anti-pd-1 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.. . ... Abbvie Biotherapeutics Inc

Dac hyp compositions and methods

The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.. . ... Abbvie Biotherapeutics Inc

Anti-pd-1 antibodies and their uses

The present disclosure provides novel anti-pd-1 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.. . ... Abbvie Biotherapeutics Inc

Anti-cmet antibody drug conjugates and methods for their use

The present disclosure provides antibody drug conjugates that bind human cmet, their methods of making, and their uses to treat patients having cancer.. . ... Abbvie Biotherapeutics Inc

Bispecific binding proteins

The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.. . ... Abbvie Biotherapeutics Inc

Anti-cd40 antibodies and their uses

The present disclosure provides novel anti-cd40 antibodies, compositions including the new antibodies, nucleic acids encoding the antibodies, and methods of making and using the same.. . ... Abbvie Biotherapeutics Inc

Method of treating multiple myeloma using combination therapies based on anti-cs1 antibodies

Compositions and methods for treating mm are provided herein.. . ... Abbvie Biotherapeutics Inc

08/31/17 / #20170247461

Dac hyp compositions

The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.. . ... Abbvie Biotherapeutics Inc

08/17/17 / #20170233481

Anti-cd25 antibodies and their uses

The present disclosure relates to antibodies directed to cd25 and uses of such antibodies, for example to suppress organ transplant rejection or to treat multiple sclerosis.. . ... Abbvie Biotherapeutics Inc

06/01/17 / #20170152540

Compositions and methods for producing glycoproteins

The present disclosure relates to methods of producing antibodies with increased levels of non-fucosylated glycoforms by culturing mammalian cells in culture media with enhanced concentrations of glycine relative to traditional basal media.. . ... Abbvie Biotherapeutics Inc

06/01/17 / #20170151344

Anti-hulrrc15 antibody drug conjugates and methods for their use

The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human lrrc15, their methods of making, and their uses to treat patients having cancer.. . ... Abbvie Biotherapeutics Inc

06/01/17 / #20170151343

Anti-hulrrc15 antibody drug conjugates and methods for their use

The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human lrrc15, their methods of making, and their uses to treat patients having cancer.. . ... Abbvie Biotherapeutics Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Abbvie Biotherapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Abbvie Biotherapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###